Literature DB >> 3023052

Transformation and stimulation of DNA synthesis in NIH-3T3 cells are a titratable function of normal p21N-ras expression.

I A McKay, C J Marshall, C Calés, A Hall.   

Abstract

A plasmid has been constructed which contains the normal human N-ras proto-oncogene under the transcriptional control of the steroid-sensitive promoter of the mouse mammary tumor virus long terminal repeat. This plasmid has been introduced into NIH-3T3 cells producing a clone of cells, T15, which is phenotypically normal in the absence of the transcription inducer, dexamethasone, and transformed when treated with high levels of the inducer. At lower levels of dexamethasone, both morphological transformation and stimulation of DNA synthesis are titratable functions of p21N-ras levels. T15 cells have been used to demonstrate that: (i) a 20- to 50-fold over-expression of normal p21ras is required for complete cellular transformation, (ii) p21N-ras expression induces DNA synthesis and the effect can be amplified by epidermal growth factor, (iii) moderate increases in normal p21ras expression can influence cell behaviour.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3023052      PMCID: PMC1167160          DOI: 10.1002/j.1460-2075.1986.tb04542.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  42 in total

1.  Development and analysis of a transformation-defective mutant of Harvey murine sarcoma tk virus and its gene product.

Authors:  M O Weeks; G L Hager; R Lowe; E M Scolnick
Journal:  J Virol       Date:  1985-05       Impact factor: 5.103

Review 2.  Autocrine growth factors and cancer.

Authors:  M B Sporn; A B Roberts
Journal:  Nature       Date:  1985 Feb 28-Mar 6       Impact factor: 49.962

3.  Requirement for ras proto-oncogene function during serum-stimulated growth of NIH 3T3 cells.

Authors:  L S Mulcahy; M R Smith; D W Stacey
Journal:  Nature       Date:  1985 Jan 17-23       Impact factor: 49.962

4.  ras-transformed cells: altered levels of phosphatidylinositol-4,5-bisphosphate and catabolites.

Authors:  L F Fleischman; S B Chahwala; L Cantley
Journal:  Science       Date:  1986-01-24       Impact factor: 47.728

5.  The involvement of activated ras genes in determining the transformed phenotype.

Authors:  C J Marshall; K Vousden; B Ozanne
Journal:  Proc R Soc Lond B Biol Sci       Date:  1985-10-22

6.  Expression of ras oncogene p21 in prostate cancer.

Authors:  M V Viola; F Fromowitz; S Oravez; S Deb; G Finkel; J Lundy; P Hand; A Thor; J Schlom
Journal:  N Engl J Med       Date:  1986-01-16       Impact factor: 91.245

7.  Alterations of myc, myb, and rasHa proto-oncogenes in cancers are frequent and show clinical correlation.

Authors:  J Yokota; Y Tsunetsugu-Yokota; H Battifora; C Le Fevre; M J Cline
Journal:  Science       Date:  1986-01-17       Impact factor: 47.728

8.  Amplification and enhanced expression of cellular oncogene c-Ki-ras-2 in a human epidermoid carcinoma of the lung.

Authors:  M Miyaki; C Sato; T Matsui; M Koike; T Mori; G Kosaki; S Takai; A Tonomura; N Tsuchida
Journal:  Jpn J Cancer Res       Date:  1985-04

9.  Human N-ras: cDNA cloning and gene structure.

Authors:  A Hall; R Brown
Journal:  Nucleic Acids Res       Date:  1985-07-25       Impact factor: 16.971

10.  Expression of p21ras in fresh primary and metastatic human colorectal tumors.

Authors:  G E Gallick; R Kurzrock; W S Kloetzer; R B Arlinghaus; J U Gutterman
Journal:  Proc Natl Acad Sci U S A       Date:  1985-03       Impact factor: 11.205

View more
  24 in total

1.  Restricted 12p amplification and RAS mutation in human germ cell tumors of the adult testis.

Authors:  H Roelofs; M C Mostert; K Pompe; G Zafarana; M van Oorschot; R J van Gurp; A J Gillis; H Stoop; B Beverloo; J W Oosterhuis; C Bokemeyer; L H Looijenga
Journal:  Am J Pathol       Date:  2000-10       Impact factor: 4.307

2.  Regulation of collagen I gene expression by ras.

Authors:  J L Slack; M I Parker; V R Robinson; P Bornstein
Journal:  Mol Cell Biol       Date:  1992-10       Impact factor: 4.272

3.  Bombesin stimulation of inositol 1,4,5-trisphosphate generation and intracellular calcium release is amplified in a cell line overexpressing the N-ras proto-oncogene.

Authors:  A C Lloyd; S A Davies; I Crossley; M Whitaker; M D Houslay; A Hall; C J Marshall; M J Wakelam
Journal:  Biochem J       Date:  1989-06-15       Impact factor: 3.857

Review 4.  RAS inhibitors in hematologic cancers: biologic considerations and clinical applications.

Authors:  D M Beaupre; R Kurzrock
Journal:  Invest New Drugs       Date:  1999       Impact factor: 3.850

5.  Antisense-fos RNA causes partial reversion of the transformed phenotypes induced by the c-Ha-ras oncogene.

Authors:  B J Ledwith; S Manam; A R Kraynak; W W Nichols; M O Bradley
Journal:  Mol Cell Biol       Date:  1990-04       Impact factor: 4.272

Review 6.  Control of myogenic differentiation by cellular oncogenes.

Authors:  M D Schneider; E N Olson
Journal:  Mol Neurobiol       Date:  1988       Impact factor: 5.590

7.  Coordinate N-ras mRNA up-regulation with mutational activation in tumorigenic guinea pig cells.

Authors:  J Doniger; J A DiPaolo
Journal:  Nucleic Acids Res       Date:  1988-02-11       Impact factor: 16.971

8.  Possible involvement of normal p21 H-ras in the insulin/insulinlike growth factor 1 signal transduction pathway.

Authors:  B M Burgering; A J Snijders; J A Maassen; A J van der Eb; J L Bos
Journal:  Mol Cell Biol       Date:  1989-10       Impact factor: 4.272

9.  Concurrent mutations in two different ras genes in acute myelocytic leukemias.

Authors:  J W Janssen; J Lyons; A C Steenvoorden; H Seliger; C R Bartram
Journal:  Nucleic Acids Res       Date:  1987-07-24       Impact factor: 16.971

10.  Identification of amino acid residues required for Ras p21 target activation.

Authors:  M S Marshall; L J Davis; R D Keys; S D Mosser; W S Hill; E M Scolnick; J B Gibbs
Journal:  Mol Cell Biol       Date:  1991-08       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.